Qol Holdings Co., Ltd.

3034

JP3266160005

Drug Retailers

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-31 am EDT			5-day change	1st Jan Change
1,492 ^JPY	+3.04%		+0.13%	-9.96%

May. 30	Qol Holdings Co., Ltd. agreed to acquire Bottom Heart Co., Ltd./Gyotoku Pharmacy Co., Ltd.	CI
May. 16	Qol Holdings Co., Ltd. acquired Dyna Co., Ltd.	CI

Qol Holdings Co., Ltd. acquired Dyna Co., Ltd.

May 15, 2024

Qol Holdings Co., Ltd. (TSE:3034) acquired Dyna Co., Ltd. on May 16, 2024.

Qol Holdings Co., Ltd. (TSE:3034) completed the acquisition of Dyna Co., Ltd. on May 16, 2024.

Latest news about Qol Holdings Co., Ltd.

Qol Holdings Co., Ltd. agreed to acquire Bottom Heart Co., Ltd./Gyotoku Pharmacy Co., Ltd.	May. 29	CI
Qol Holdings Co., Ltd. acquired Dyna Co., Ltd.	May. 15	CI
Qol to Secure 25 Billion Yen Bank Loan	Mar. 19	MT
Qol Holdings Co., Ltd. Announces Notice of Borrowing (Refinancing) of Funds	Mar. 18	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	Feb. 02	CI
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024	Feb. 02	CI
Qol Holdings Co., Ltd. acquired KI Chozai Yakkyoku Ltd.	Dec. 10	CI
Qol Holdings Co., Ltd. acquired Art Co., Ltd. and AM Medical Co., Ltd. and Haraigawachozai Pharmacy Co., Ltd.	Nov. 21	CI
Japanese Shares End Lower; BoJ Expresses More Confidence in Wage Growth	23-10-03	MT
Qol Holdings Acquires 54,000 Shares in Daiichi Sankyo Espha	23-10-02	MT
Insmed Shares Rise After Announcing Positive Topline Results from Study of Lung Disease Treatment Arikayce	23-09-05	MT
Qol Holdings to Borrow Funds from Mizuho Bank	23-09-01	MT
Biogen's Alzheimer's Treatment Leqembi May be Eligible for Full Approval, US FDA's Advisers Say	23-06-07	MT
Strong Economic Reports Give Major Lift to Japanese Stocks; Rakuten Plans Up to 332 Billion Yen Equity Raise	23-05-17	MT
Daiichi Sankyo to Sell Pharmaceutical Subsidiary to Qol for 25 Billion Yen; Qol Ups Fiscal Year Earnings Projection	23-05-17	MT
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Fiscal Year Ending March 31, 2024	23-05-11	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter End and Fiscal Year Ending March 31, 2024	23-05-11	CI
Qol Holdings Co., Ltd. Declares a Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 13, 2023	23-05-11	CI
Qol Holdings Co., Ltd. Declares Commemorative Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 13, 2023	23-05-11	CI
Qol Holdings Co., Ltd. Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Full Year Ending of March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. completed the acquisition of Power Pharmacy Co., Ltd. from Power Holdings, Inc.	23-01-30	CI
Qol Holdings Acquires 38 Dispensing Pharmacies with Power Pharmacy Takeover	23-01-09	MT
Qol Holdings Co., Ltd. concluded a share transfer agreement to acquire Power Pharmacy Co., Ltd. from Power Holdings, Inc.	23-01-05	CI

Qol Holdings Co.,Ltd., formerly Qol Co., Ltd. is engaged in the operation of insurance pharmacies and Business Process Outsourcing (BOP) commission business. The Company operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO) business, Contract Research Organization (CRO) business, medical related business and the wholesale of medicine products, cosmetic products and daily necessities through its subsidiaries.

Sector

Drug Retailers

Calendar

2024-08-01 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Qol Holdings Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

	1st Jan change	Capi.
QOL HOLDINGS CO., LTD.	-9.96%	354M
RAIA DROGASIL S.A.	-14.73%	8.2B
NIHON CHOUZAI CO.,LTD.	-0.86%	264M
SALUS, LJUBLJANA, D. D.	+11.11%	229M
PETMED EXPRESS, INC.	-43.65%	86.89M
GREEN CROSS HEALTH LIMITED	-10.09%	86.36M
MEDICAL IKKOU GROUP CO.,LTD.	+24.09%	61.19M

Retail - Drugs without Grocery